Stella-Jones (OTCMKTS:STLJF) Shares Gap Up – Time to Buy?

Stella-Jones Inc. (OTCMKTS:STLJF) gapped up before the market opened on Wednesday . The stock had previously closed at $52.81, but opened at $55.70. Stella-Jones shares last traded at $55.70, with a volume of 100 shares trading hands.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Desjardins restated a “buy” rating on shares of Stella-Jones in a research note on Thursday, May 7th. Scotiabank upgraded shares of Stella-Jones from a “sector perform” rating to an “outperform” rating in a research note on Thursday, January 29th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy”.

Stella-Jones Stock Performance

The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.34 and a current ratio of 7.40. The firm’s 50 day moving average is $60.44 and its 200-day moving average is $63.56. The stock has a market capitalization of $3.03 billion and a price-to-earnings ratio of 37.73.

Stella-Jones (OTCMKTS:STLJF) last posted its earnings results on Wednesday, May 6th. The company reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.84 by ($0.02). Stella-Jones had a net margin of 8.66% and a return on equity of 15.08%. The firm had revenue of $568.67 million during the quarter, compared to analyst estimates of $583.31 million.

About Stella-Jones

Stella-Jones Inc is a North American producer and distributor of pressure-treated wood products used in infrastructure, utility and residential applications. The company’s core offerings include treated railroad ties, utility poles, crossarms, landscape timbers and posts designed to withstand environmental stresses and extend service life. These products support a range of end markets from railways and power transmission to fencing and outdoor construction.

Founded in 1970 and headquartered in Montreal, Canada, Stella-Jones has grown through both organic expansion and targeted acquisitions to establish a network of manufacturing and treatment facilities across Canada and the United States.